Phase II funding BEL secured 2.2M in Phase II funding from the National Institutes of Aging for an FDA-monitored clinical trial. Sales opportunity: offer specialized research equipment, data analytics, and compliant study support to scale ongoing trials and expand into related aging and cognitive health programs.

Clinical trial focus Active collaboration on FDA-monitored trials evaluating Electric Sleep Therapy for seniors with Mild Cognitive Impairment. Sales opportunity: present end-to-end hardware, acquisition systems, sleep study software, and regulatory-friendly services to accelerate trial timelines.

Academic origins Originating from the University of Oregon and evolved through EGI, BEL has deep ties to academic research and student training. Sales opportunity: partner for university-grade instrumentation, robust training packages, and educator-friendly licenses that align with SBIR project requirements.

Moderate revenue scale Current revenue range is 1M to 10M with a lean employee base. Sales opportunity: provide scalable, cost-efficient medical equipment solutions, service plans, and phased deployment options tailored for mid-sized research-focused manufacturers.

Tech ecosystem Tech stack includes Google Ads, Squarespace, Microsoft 365, and PHP-based systems. Sales opportunity: offer integrated marketing analytics, CRM/ERP compatibility, cybersecurity hardening, and custom software integrations to modernize their digital backbone for growth.